HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.

Abstract
Peptichemio is a complex of six peptides containing m-L-sarcolysin which is used in cancer chemotherapy. One of the peptides, L-propyl-m-sarcolysyl-L-p-fluorophenylalanine (PSF), is highly toxic to melanoma cells. We have compared the effects of melphalan, m-L-sarcolysin and PSF on human melanoma cell lines. PSF was 35-fold and 28-fold more toxic to RPMI 8322 melanoma cells than melphalan and m-L-sarcolysin, respectively. Similar differences in the cytotoxic effects of PSF and m-L-sarcolysin were also seen with two other melanoma cell lines. The cytotoxicity of both PSF and m-L-sarcolysin to RPMI 8322 melanoma cells was potentiated by depletion of cellular glutathione. Both PSF and m-L-sarcolysin caused a protracted induction of DNA cross-links in RPMI 8322 cells, with maximum at 24 hours after drug exposure. PSF induced 9-fold higher levels of DNA interstrand cross-links than m-L-sarcolysin, indicating that the increased cytotoxicity of this drug is associated with a more efficient induction of DNA damage.
AuthorsJ Hansson, R Lewensohn, U Ringborg
JournalAnticancer research (Anticancer Res) 1991 Sep-Oct Vol. 11 Issue 5 Pg. 1725-30 ISSN: 0250-7005 [Print] Greece
PMID1768043 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
  • Dipeptides
  • Oligopeptides
  • propyl-3-sarcolysin-4-fluorophenylalanine
  • metamelfalan
  • p-Fluorophenylalanine
  • Glutathione
  • Melphalan
Topics
  • DNA, Neoplasm (drug effects)
  • Dipeptides (toxicity)
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Glutathione (metabolism)
  • Humans
  • Melanoma (chemistry, genetics)
  • Melphalan (analogs & derivatives, toxicity)
  • Oligopeptides
  • Tumor Cells, Cultured (drug effects)
  • p-Fluorophenylalanine (analogs & derivatives, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: